Heart failure treatment
Total Trials
8
As Lead Sponsor
As Collaborator
0
Total Enrollment
496
NCT00326690
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
Phase: N/A
Role: Lead Sponsor
Start: Nov 30, 2005
Completion: Dec 31, 2008
NCT01568138
Prospective Study of the BioVentrix PliCath HF™ System for the Treatment of Ischemic Cardiomyopathy
Start: Aug 31, 2010
Completion: Aug 31, 2015
NCT01568164
Safety and Efficacy Study of the BioVentrix PliCath HF System
Start: Mar 31, 2012
Completion: Dec 31, 2019
NCT02553785
Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy
Phase: Phase 1
Start: Jun 30, 2015
NCT02931240
BioVentrix Revivent TC™ System Clinical Study
Start: Aug 29, 2017
Completion: Jun 30, 2027
NCT03845127
Randomized Evaluation and Verification of Ventricular Enhancement
Start: Jan 1, 2020
Completion: Dec 31, 2024
NCT06813820
RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial
Start: Aug 31, 2025
Completion: Aug 31, 2032
Loading map...